# OnCo record georgina-long (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/georgina-long/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "georgina-long" ;
  schema:name "Georgina V. Long"@en ;
  schema:description "Melanoma trialist who led COMBI-d, COMBI-AD and NADINA, moving immunotherapy before surgery for stage III disease."@en ;
  schema:url <https://onco.cc/people/georgina-long/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Georgina_Long>, <https://orcid.org/0000-0001-8894-3545> ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Long%20GV%5BAuthor%5D%20melanoma> ;
  onco:tag "melanoma", "neoadjuvant", "australia" ;
  schema:jobTitle "Co-Medical Director, Melanoma Institute Australia; Chair of Melanoma Medical Oncology and Translational Research, University of Sydney" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/braf/>, <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/ctla4/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/> ;
  onco:institutions <https://onco.cc/institutions/melanoma-institute-australia/> ;
  onco:trials <https://onco.cc/trials/combi-ad/>, <https://onco.cc/trials/nadina/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nadina-nejm-2024/> ;
  schema:affiliation <https://onco.cc/institutions/melanoma-institute-australia/> .